The company’s first product, the inReach System, provides minimally invasive electromagnetic navigation (similar to GPS) to distant regions of the lungs, enabling doctors to diagnose lung cancer at earlier stages and potentially provide more timely treatment.
Daniel Sullivan, president and CEO of superDimension, said: “This round of financing will accelerate the company’s investment in sales and marketing to meet and accelerate the growing worldwide demand for inReach.”